Review



psma 617  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    MedChemExpress psma 617
    Psma 617, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 23 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/psma 617/product/MedChemExpress
    Average 93 stars, based on 23 article reviews
    psma 617 - by Bioz Stars, 2026-06
    93/100 stars

    Images



    Similar Products

    psma 617  (MedChemExpress)
    93
    MedChemExpress psma 617
    Psma 617, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/psma 617/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    psma 617 - by Bioz Stars, 2026-06
    93/100 stars
    		  Buy from Supplier
    177lu lu psma 617  (Novartis)
    86
    Novartis 177lu lu psma 617
    177lu Lu Psma 617, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/177lu lu psma 617/product/Novartis
    Average 86 stars, based on 1 article reviews
    177lu lu psma 617 - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier
    177lu lu psma 617 pluvictotm novartis  (Novartis)
    86
    Novartis 177lu lu psma 617 pluvictotm novartis
    177lu Lu Psma 617 Pluvictotm Novartis, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/177lu lu psma 617 pluvictotm novartis/product/Novartis
    Average 86 stars, based on 1 article reviews
    177lu lu psma 617 pluvictotm novartis - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier
    psma 617 psma novartis pharmaceutic als psma nct06402331 psma r2 psma novartis pharmaceutic als dota daratumumab cd38 phase 1 ongoi  (Novartis)
    86
    Novartis psma 617 psma novartis pharmaceutic als psma nct06402331 psma r2 psma novartis pharmaceutic als dota daratumumab cd38 phase 1 ongoi
    Psma 617 Psma Novartis Pharmaceutic Als Psma Nct06402331 Psma R2 Psma Novartis Pharmaceutic Als Dota Daratumumab Cd38 Phase 1 Ongoi, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/psma 617 psma novartis pharmaceutic als psma nct06402331 psma r2 psma novartis pharmaceutic als dota daratumumab cd38 phase 1 ongoi/product/Novartis
    Average 86 stars, based on 1 article reviews
    psma 617 psma novartis pharmaceutic als psma nct06402331 psma r2 psma novartis pharmaceutic als dota daratumumab cd38 phase 1 ongoi - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier
    benchmark trt 177 lu psma 617  (Novartis)
    86
    Novartis benchmark trt 177 lu psma 617
    Benchmark Trt 177 Lu Psma 617, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/benchmark trt 177 lu psma 617/product/Novartis
    Average 86 stars, based on 1 article reviews
    benchmark trt 177 lu psma 617 - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier
    177lu psma 617  (Novartis)
    86
    Novartis 177lu psma 617
    177lu Psma 617, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/177lu psma 617/product/Novartis
    Average 86 stars, based on 1 article reviews
    177lu psma 617 - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier
    177 lu lu psma 617  (Novartis)
    86
    Novartis 177 lu lu psma 617
    Head-to-head comparison between [ 161 Tb]Tb-PSMA-617 and [ <t>177</t> <t>Lu]Lu-PSMA-617,</t> including preclinical dosimetry results in patients with mCRPC. (A) Mean absorbed doses (Gy/GBq) accumulated to kidneys, liver, parotid glands and submandibular glands determined for [ 161 Tb]Tb-PSMA-617 and [ 177 Lu]Lu-PSMA-617 over all patients. (B) Absorbed doses in tumor lesions determined after application of [ 161 Tb]Tb-PSMA-617 and [ 177 Lu]Lu-PSMA-617, respectively. (C) Mean tumor lesion absorbed dose per patient, and (D) absorbed dose in each individual tumor lesion. Copyrights © 2024 IVYSPRING.
    177 Lu Lu Psma 617, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/177 lu lu psma 617/product/Novartis
    Average 86 stars, based on 1 article reviews
    177 lu lu psma 617 - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Head-to-head comparison between [ 161 Tb]Tb-PSMA-617 and [ 177 Lu]Lu-PSMA-617, including preclinical dosimetry results in patients with mCRPC. (A) Mean absorbed doses (Gy/GBq) accumulated to kidneys, liver, parotid glands and submandibular glands determined for [ 161 Tb]Tb-PSMA-617 and [ 177 Lu]Lu-PSMA-617 over all patients. (B) Absorbed doses in tumor lesions determined after application of [ 161 Tb]Tb-PSMA-617 and [ 177 Lu]Lu-PSMA-617, respectively. (C) Mean tumor lesion absorbed dose per patient, and (D) absorbed dose in each individual tumor lesion. Copyrights © 2024 IVYSPRING.

    Journal: Theranostics

    Article Title: Contemporary opportunities and potential of Auger electron-emitting theranostics

    doi: 10.7150/thno.124671

    Figure Lengend Snippet: Head-to-head comparison between [ 161 Tb]Tb-PSMA-617 and [ 177 Lu]Lu-PSMA-617, including preclinical dosimetry results in patients with mCRPC. (A) Mean absorbed doses (Gy/GBq) accumulated to kidneys, liver, parotid glands and submandibular glands determined for [ 161 Tb]Tb-PSMA-617 and [ 177 Lu]Lu-PSMA-617 over all patients. (B) Absorbed doses in tumor lesions determined after application of [ 161 Tb]Tb-PSMA-617 and [ 177 Lu]Lu-PSMA-617, respectively. (C) Mean tumor lesion absorbed dose per patient, and (D) absorbed dose in each individual tumor lesion. Copyrights © 2024 IVYSPRING.

    Article Snippet: The key point is regulatory milestones have accelerated clinical translation: [ 177 Lu]Lu-DOTATATE (Lutathera ® , Novartis) was approved by the U.S. Food and Drug Administration (FDA) on January 26, 2018, for somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs) , , [ 68 Ga]Ga-PSMA-11 (Locametz ® , Novartis) was approved on December 1, 2020, for prostate-specific membrane antigen (PSMA)-positive prostate cancer imaging , ; and [ 177 Lu]Lu-PSMA-617 (Pluvicto ® , Novartis) was approved on March 23, 2022, for PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) , .

    Techniques: Comparison